Technical Analysis for ACRS - Aclaris Therapeutics, Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Strong | Up | Up | Down |
Historical ACRS trend table... |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Crossed Above 20 DMA | Bullish | 0.00% | |
Bollinger Band Squeeze | Range Contraction | 0.00% | |
Outside Day | Range Expansion | 0.00% | |
Bollinger Band Squeeze | Range Contraction | 5.00% | |
BB Squeeze Started | Range Contraction | 5.00% | |
1,2,3 Pullback Bullish | Bullish Swing Setup | 7.79% | |
Boomer Buy Setup | Bullish Swing Setup | 7.79% | |
Non-ADX 1,2,3,4 Bullish | Bullish Swing Setup | 7.79% | |
Inside Day | Range Contraction | 7.79% | |
Fell Below 20 DMA | Bearish | 5.99% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
Alert | Time | |
---|---|---|
Rose Above 10 DMA | 2 days ago | |
10 DMA Resistance | 2 days ago | |
Up 5% | 2 days ago | |
Rose Above 20 DMA | 2 days ago | |
60 Minute Opening Range Breakout | 2 days ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 02/25/2020
Aclaris Therapeutics, Inc., a clinical-stage specialty pharmaceutical company, focuses on identifying, developing, and commercializing topical drugs to address various unmet needs in dermatology. Its lead drug candidate is A-101, a hydrogen peroxide topical solution that has completed three Phase II clinical trials for the treatment of seborrheic keratosis (SK), a common non-malignant skin tumor. The company is also developing A-101 as a prescription treatment for common warts; and A-102, a proprietary topical gel dosage form of hydrogen peroxide for the treatment of SK and common warts. Aclaris Therapeutics, Inc. was founded in 2012 and is headquartered in Malvern, Pennsylvania.
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Pharmaceutical Chemical Substances Hydrogen Dermatology Stage Specialty Pharmaceutical Hydrogen Peroxide Topical Medication Common Warts Keratosis
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Pharmaceutical Chemical Substances Hydrogen Dermatology Stage Specialty Pharmaceutical Hydrogen Peroxide Topical Medication Common Warts Keratosis
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 25.48 |
52 Week Low | 0.7 |
Average Volume | 3,720,066 |
200-Day Moving Average | 5.55 |
50-Day Moving Average | 14.46 |
20-Day Moving Average | 21.97 |
10-Day Moving Average | 22.40 |
Average True Range | 2.13 |
ADX | 49.63 |
+DI | 27.23 |
-DI | 13.01 |
Chandelier Exit (Long, 3 ATRs ) | 19.08 |
Chandelier Exit (Short, 3 ATRs ) | 22.46 |
Upper Bollinger Band | 24.29 |
Lower Bollinger Band | 19.65 |
Percent B (%b) | 0.57 |
BandWidth | 21.12 |
MACD Line | 1.96 |
MACD Signal Line | 2.63 |
MACD Histogram | -0.6703 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 26.74 | ||||
Resistance 3 (R3) | 26.54 | 24.85 | 25.99 | ||
Resistance 2 (R2) | 24.85 | 23.72 | 24.95 | 25.74 | |
Resistance 1 (R1) | 23.57 | 23.02 | 24.21 | 23.77 | 25.50 |
Pivot Point | 21.88 | 21.88 | 22.21 | 21.98 | 21.88 |
Support 1 (S1) | 20.60 | 20.75 | 21.24 | 20.80 | 19.06 |
Support 2 (S2) | 18.91 | 20.05 | 19.01 | 18.82 | |
Support 3 (S3) | 17.63 | 18.91 | 18.57 | ||
Support 4 (S4) | 17.83 |